Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1Gastrointestinal 1

Conditions

Motor Activity 20Polycystic Ovary Syndrome 10Prostatic Neoplasms 7Breast Neoplasms 6Neoplasms 5Colorectal Neoplasms 4Insulin Resistance 3Lung Neoplasms 2Fatigue 2Esophageal Neoplasms 2Cardiotoxicity 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Primary Dysautonomias 1Pediatric Brain Tumor 1Ovarian Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Lymphoma, Follicular 1Lupus Erythematosus, Systemic 1Inflammation 1Hodgkin Disease 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Disease 1Diabetes Mellitus, Type 1 1Chemotherapy-Related Cognitive Impairment 1Cardiovascular Diseases 1

Interventions

Cisplatin 141Radiotherapy 115Cetuximab 95Docetaxel 69Radiotherapy, Intensity-Modulated 55Carboplatin 47pembrolizumab 46Surveys and Questionnaires 46Paclitaxel 41Fluorouracil 39Radiation 29Blood Specimen Collection 27Drug Therapy 26Erlotinib Hydrochloride 23Nivolumab 21Surgical Procedures, Operative 17Standard of Care 16Magnetic Resonance Spectroscopy 16Radiosurgery 14Pemetrexed 14Gemcitabine 14Everolimus 13Celecoxib 13durvalumab 12Low-Level Light Therapy 12Immunohistochemistry 12Cyclophosphamide 12Capecitabine 12Amifostine 12Chemoradiotherapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Head and Neck Neoplasms × High-Intensity Interval Training × Clear all
NCT03252821 2020-03-17

Effects of High-intensity Training Compared to Resistance Training in Cancer Patients Undergoing Radiotherapy

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase NA Completed
78 enrolled
GastrointestinalGenitourinaryHead & Neck

Head and Neck Neoplasms, Prostatic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡